Literature DB >> 1957188

Charging for health care: evidence on the utilisation of NHS prescribed drugs.

M Ryan1, S Birch.   

Abstract

The effects of regular and frequent increases in charges for health care on patient utilisation are analysed using monthly data on National Health Service (NHS) prescribed drugs in England for the period 1979-1985. Using a partial adjustment model a utilisation equation of prescribed drugs is estimated for the adult non-elderly population that is subject to the NHS prescription charge. The maximum likelihood estimates of the coefficients of the equation imply that the charges policy followed in the U.K. has led to a significant reduction in utilisation among non-exempt patients. The short-run price elasticity of utilisation is -0.109 and the long-run elasticity is -0.09, while exempt utilisation is unaffected. Although the policy has generated a reduction in the central Government expenditure for prescribed drugs, on the basis of these estimates around 66% of these savings arise from the reduction in service use as opposed to the increased revenue per item of drugs.

Entities:  

Mesh:

Year:  1991        PMID: 1957188     DOI: 10.1016/0277-9536(91)90022-5

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  11 in total

1.  Impact of consumer fees on drug utilisation.

Authors:  D G Smith; D M Kirking
Journal:  Pharmacoeconomics       Date:  1992-10       Impact factor: 4.981

2.  The UK indicative prescribing scheme: background and operation.

Authors:  J Bligh; T Walley
Journal:  Pharmacoeconomics       Date:  1992-08       Impact factor: 4.981

3.  Prescription charges: change overdue? Britain can learn from systems of copayments based on drugs' effectiveness.

Authors:  T Walley
Journal:  BMJ       Date:  1998-08-22

4.  Lessons from international experience in controlling pharmaceutical expenditure. I: Influencing patients.

Authors:  N Freemantle; K Bloor
Journal:  BMJ       Date:  1996-06-08

5.  The impact of increasing patient prescription drug cost sharing on therapeutic classes of drugs received and on the health status of elderly HMO members.

Authors:  R E Johnson; M J Goodman; M C Hornbrook; M B Eldredge
Journal:  Health Serv Res       Date:  1997-04       Impact factor: 3.402

6.  The role of insurance claims databases in drug therapy outcomes research.

Authors:  N J Lewis; J T Patwell; B A Briesacher
Journal:  Pharmacoeconomics       Date:  1993-11       Impact factor: 4.981

7.  Impact of the reclassification of omeprazole on the prescribing and sales of ulcer healing drugs.

Authors:  Teerapon Dhippayom; Roger Walker
Journal:  Pharm World Sci       Date:  2006-10-26

8.  The creeping privatisation of NHS prescribing.

Authors:  I Heath
Journal:  BMJ       Date:  1994-09-10

9.  Financial and family burden associated with cancer treatment in Ontario, Canada.

Authors:  Christopher J Longo; Margaret Fitch; Raisa B Deber; A Paul Williams
Journal:  Support Care Cancer       Date:  2006-05-30       Impact factor: 3.359

10.  What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries.

Authors:  Marin C Gemmill; Sarah Thomson; Elias Mossialos
Journal:  Int J Equity Health       Date:  2008-05-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.